ICAM1 and breast cancer: The findings demonstrated that the ICAM-1 high expression group’s breast cancer tissues had greater stromal, immunological, and overall ESTIMATE scores than the low expression group’s, indicating a considerably higher rate of immune cell infiltration in the high expression group (Figure 4a).